Disclosure 0001470831-26-000813-2

SEC FORM 4

$279,750.00

Bicara Therapeutics Inc. (BCAX)

Sale of 10,000 shares at $27.975 per share.

Reporting Person Mazumdar Claire · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000813 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Bicara Therapeutics Inc. (BCAX)." Disclosed 2026-08-12. https://desqlong.com/cards/0001470831-26-000813-2 (retrieved 2026-09-26).